HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wahlsten, J. L. Articles by Ramakrishnan, S. Search for Related Content PubMed PubMed Citation Articles by Wahlsten, J. L. Articles by Ramakrishnan, S.

Separation of Function Between the Domains of Toxic Shock Syndrome Toxin-1¹

University of Minnesota, Department of Pharmacology, Minneapolis, MN 55455

Toxic shock syndrome toxin-1 (TSST1) is a superantigenic exotoxin produced by certain strains of Staphylococcus aureus. Structurally, TSST1 is composed of two domains: residues determined by crystallography to directly interact with MHC II molecules reside within the N-terminal domain, while TSST1 residues critical for superantigenicity are within the C-terminal domain. In this study, we expressed the individual N- and C-terminal domains of TSST1 in Escherichia coli and studied their biologic activities. The TSST1 N-terminal domain (TSST(1–87)) did not induce proliferation of human PBLs or release of TNF-ß, but did induce TNF- release. However, TSST1-elicited proliferation and release of both TNF isoforms were inhibited by a molar excess of TSST(1–87). The TSST1 C-terminal domain (TSST(88–194)) did not bind MHC II molecules, yet it elicited production of TNF- and TNF-ß, and induced TCR Vß-specific proliferation similarly to intact TSST1. When covalently cross-linked to tumor cells, TSST(88–194) elicited a local in vivo antitumor response indistinguishable from TSST1. Although intact TSST1 causes lethal shock in vivo, the individual domains of this molecule may have therapeutic potential: the N-terminal domain to antagonize lymphocyte activation and TNF release during acute TSST1-precipitated toxic shock syndrome, and the C-terminal domain to stimulate antitumor responses without MHC II binding.

This article has been cited by other articles:

				C. Guillen, I. B. McInnes, D. M. Vaughan, S. Kommajosyula, P. H. C. Van Berkel, B. P. Leung, A. Aguila, and J. H. Brock Enhanced Th1 Response to Staphylococcus aureus Infection in Human Lactoferrin-Transgenic Mice J. Immunol., April 15, 2002; 168(8): 3950 - 3957. [Abstract] [Full Text] [PDF]

				J. L. Wahlsten, C. D. Mills, and S. Ramakrishnan Antitumor Response Elicited by a Superantigen- Transmembrane Sequence Fusion Protein Anchored onto Tumor Cells J. Immunol., December 15, 1998; 161(12): 6761 - 6767. [Abstract] [Full Text] [PDF]